Clinical Trials Directory

Trials / Terminated

TerminatedNCT01973348

Comparison of AmblyzTM Glasses and Patching for Amblyopia

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Indiana University · Academic / Other
Sex
All
Age
3 Years – 8 Years
Healthy volunteers
Not accepted

Summary

Electronic eyeglasses, Amblyz™glasses, are a new medical device designed to treat amblyopia, which intermittently become opaque and provide effective occlusion for 50% of the time they are worn. A non-randomized study reported that Amblyz glasses yield an improvement in the amblyopic eye and offer an alternative effective treatment. We are unaware of any randomized clinical trial reports of response to AmblyzTM glasses treatment of amblyopia. Our hypothesis: Amblyz™glasses can improve visual acuity of the amblyopic eye as effective as traditional patching treatment. The primary objective is to determine if AmblyzTM equally treats moderate amblyopia as the standard 2-hour patching treatment and AmblyzTM equally treats severe amblyopia as the standard 6-hour patching treatment. This study is designed to evaluate the effectiveness of a novel amblyopia treatment, AmblyzTM glasses, in treating amblyopia. Moderate amblyopia: Children ages 3 to \<8 years with visual acuity of 20/40 to 20/80 in the amblyopic eye will be enrolled and randomized into two groups: 4-hour AmblyzTM glasses treatment group and standard 2-hour patching control group. Severe amblyopia: Children ages 3 to \<8 years with visual acuity of 20/100 to 20/400 in the amblyopic eye will be enrolled and randomized into two groups: 12-hour AmblyzTM glasses treatment group and standard 6-hour patching control group.

Conditions

Interventions

TypeNameDescription
DEVICE4-hour AmblyZ glasses4-hour AmblyZ glasses for moderate amblyopia
DEVICE12-hour AmblyZ glasses12-hour AmblyZ glasses for severe amblyopia
DEVICE2-hour patching2-hour patching for moderate amblyopia
DEVICE6-hour patching6-hour patching for severe amblyopia

Timeline

Start date
2013-11-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2013-10-31
Last updated
2017-08-25
Results posted
2017-07-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01973348. Inclusion in this directory is not an endorsement.